Cefotaxime vs Ceftriaxone for the Prolongation of Latency Period in Preterm Premature Rupture of Membranes


  • Shinta Dewi Rasti Faculty of Medicine, Universitas Airlangga
  • Maftuchah Rochmanti Department of Pharmacology, Faculty of Medicine, Universitas Airlangga
  • Relly Yanuari Primariawan Department of Obstetric and Gynecology, Faculty of Medicine, Universitas Airlangga




PPROM, Antibiotic, Cefotaxime, Ceftriaxone, Cephalosporin, Latency period


Introduction: Antibiotics are well known and recommended as the main therapy for preterm premature rupture of membranes (PPROM.) But the research on antibiotics other than the recommended macrolides regimens is still lacking. This research aims to evaluate whether there are effects differences of cefotaxime and ceftriaxone given on pregnancy with PPROM by comparing the duration of the latency period and the infants outcomes.

Material and Methods: Data was taken retrospectively through medical records at Dr. Soetomo Surabaya General Hospital, Indonesia during the period of January-December 2017. The inclusion criteria were a history of PPROM in pregnancy <37 weeks, given cefotaxime or ceftriaxone therapy, and have labor data. The analysis was performed by the Mann-Whitney comparison test for the latency period and Fisher's exact test for infant outcomes.

Results: There were 52 samples obtained. The antibiotics used were cefotaxime 3x1gr (A) and ceftriaxone 2x1gr (B). The results of the analysis showed that there were no significant differences between the types of antibiotics with the length of the latency period, with a value of p = 0,601 (p>0,05), where group A had a median of 52,67 hours and group B was 34,17 hours. Group A was found to be more able to extend the latency period for >48 hours with a percentage of 57,8%, whereas in group B only 42,9%. There are no significant differences in infant outcomes; infant birth weight and Apgar score among the two therapies used.

Conclusion: Cefotaxime was more preferably to be used in the Dr. Soetomo Surabaya General Hospital. Nevertheless, ceftriaxone can still be a good choice for PPROM therapy since both cephalosporins have succeeded in preventing infections in women with PPROM.


Medina TM, Hill DA. Preterm premature rupture of membranes:

diagnosis and management. Am Fam Physician 2006; 73(4):659-

Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis

and management of preterm premature rupture of membranes.

Rev Obstet Gynecol 2008; 1(1):11-22.

Mercer BM. Preterm premature rupture of the membranes:

current approaches to evaluation and management. Obstet

Gynecol Clin North Am 2005; 32(3):411-28.

Stock O, Gordon L, Kapoor J, et al. Chorioamnionitis Occurring

in Women With Preterm Rupture of the Fetal Membranes Is

Associated With a Dynamic Increase in mRNAs Coding Cytokines

in the Maternal Circulation. Reprod Sci 2015; 22(7):852-859.

Bowes WA Jr. The role of antibiotics in the prevention of preterm

birth. F1000 Med Rep 2009; 1. pii: 22. doi: 10.3410/M1-22

Johnston MM, Sanchez-Ramos L, Vaughn AJ, Todd MW,

Benrubi GI. Antibiotic therapy in preterm premature rupture of

membranes: a randomized, prospective, double-blind trial. Am

J Obstet Gynecol 1990; 163(3):743-747.

Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm

premature rupture of membranes. Cochrane Database Syst Rev

; (4):CD001058.

Melamed N, Hadar E, Ben-Haroush A, Kaplan B, Yogev Y.

Factors affecting the duration of the latency period in preterm

premature rupture of membranes. J Matern Fetal Neonatal Med

; 22(11):1051-1056.

Cousens S, Blencowe H, Gravett M, Lawn JE. Antibiotics for preterm

pre-labour rupture of membranes: prevention of neonatal

deaths due to complications of pre-term birth and infection. Int

J Epidemiol 2010; 39 Suppl 1(Suppl 1):134-143.

Schmitz T, Sentilhes L, Lorthe E, Gallot D, Madar H, Doret-Dion

M, Beucher G, Charlier C, Cazanave C, Delorme P, Garabedian

C, Azria É, Tessier V, Senat MV, Kayem G. Preterm premature

rupture of membranes: CNGOF Guidelines for clinical practice

- Short version. Gynecol Obstet Fertil Senol 2018; 46(12):998-

Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J,

Naberezhnev Y, Winarno AS, Seliger G. Mid-trimester preterm

premature rupture of membranes (PPROM): etiology, diagnosis,

classification, international recommendations of treatment

options and outcome. J Perinat Med 2018; 46(5):465-488.

Machado DCS, Dias JdM, Rosado LEP. Antibiotic prophylaxis

in preterm rupture of membranes. Hum Reprod Arch 2018;


Saghafi N, Pourali L, Ghazvini K, Maleki A, Ghavidel M,

Karbalaeizadeh Babaki M. Cervical bacterial colonization in

women with preterm premature rupture of membrane and

pregnancy outcomes: A cohort study. Int J Reprod Biomed

(Yazd) 2018; 16(5):341-348.

Zeng L, Zhang L, Shi J, Gu L, Grogan W, Gargano MM,

Chen C. The primary microbial pathogens associated with

premature rupture of the membranes in China: A systematic

review. Taiwanese Journal of Obstetric and Gynecology 2014;


Li YY, Kong CW, To WWK. Pathogens in preterm prelabour

rupture of membranes and erythromycin for antibiotic

prophylaxis: a retrospective analysis. Hong Kong Med J 2019;


Adewumi OA, Olofinbiyi BA, Oyekale OT, Loto OM, Abu SH,

Sotunsa JO. Microbiological Pattern in Preterm Prelabour

Rupture of the Fetal Membranes in South-Western Nigeria.

Obstet Gynecol Int J 2017; 6(4):00215

Majdawati A. Pola Kepekaan Kuman Penyebab Infeksi Saluran

Kemih dan Resistensinya. Mutiara Medika 2001; 1:55-63.

Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Akbari

Cheshmeh M, Salehian Omran D. A survey on urinary

tract infections associated with the three most common

uropathogenic bacteria. Maedica (Buchar) 2010; 5(2):111-115.

Thompson RL, Wright AJ. Cephalosporin antibiotics. Mayo

Clinic Proceedings 1983; 58(2):79-87.

Kalman D, Barriere SL. Review of the pharmacology,

pharmacokinetics, and clinical use of cephalosporins. Tex Heart

Inst J 1990; 17(3):203-215.

Klein NC, Cunha BA. Third-generation cephalosporins. Med Clin

North Am 1995; 79(4):705-719.

Sá Del Fiol F, Gerenutti M, Groppo FC. Antibiotics and pregnancy.

Pharmazie 2005; 60:483-493.

Mandell LA, Bergeron MG, Ronald AR, Vega C, Harding G,

Saginur R, Feld R, Duperval R, Landis SJ, Miedzinski LJ, et al.

Once-daily therapy with ceftriaxone compared with daily

multiple-dose therapy with cefotaxime for serious bacterial

infections: a randomized, double-blind study. J Infect Dis 1989;


Smith CR, Petty BG, Hendrix CW, Kernan WN, Garver PL, Fox

K, Beamer A, Carbone K, Threlkeld M, Lietman PS. Ceftriaxone

compared with cefotaxime for serious bacterial infections. J

Infect Dis 1989; 160(3):442-447.

Simmons BP, Gelfand MS, Grogan J, Craft B. Cefotaxime twice

daily versus ceftriaxone once daily. A randomized controlled

study in patients with serious infections. Diagn Microbiol Infect

Dis 1995; 22(1-2):155-157.

Illahi RK, Pramestutie HR, Susilaningtyas WS. Cost-Effectiveness

Analysis of Cefotaxime, Ceftriaxone, and Levofloxacine in

the Treatment of Thyphoid Fever: A Study From Kanjuruhan

Hospital, Malang, Indonesia. Value in Health 2018; 21:S65.

Bonanno C, Wapner RJ. Antenatal corticosteroids in the

management of preterm birth: are we back where we started?.

Obstet Gynecol Clin North Am 2012; 39(1):47-63.

Fortunato SJ, Welt SI, Eggleston M, Cole J, Bryant EC, Dodson

MG. Prolongation of the latency period in preterm premature

rupture of the membranes using prophylactic antibiotics and

tocolysis. J Perinatol 1990; 10(3):252-6.

Lee J, Romero R, Kim SM, Chaemsaithong P, Yoon BH. A

new antibiotic regimen treats and prevents intra-amniotic

inflammation/infection in patients with preterm PROM. J

Matern Fetal Neonatal Med 2016; 29(17):2727-37.

Kenyon S, Taylor DJ, Tarnow-Mordi WO; ORACLE Collaborative

Group. ORACLE--antibiotics for preterm prelabour rupture of

the membranes: short-term and long-term outcomes. Acta

Paediatr Suppl 2002; 91(437):12-5.

Buitendijk SE. Erythromycin for premature rupture of

membranes is beneficial for infant. Ned Tijdschr Geneeskd

; 145(38):1828-31.

Kibret M, Abera B. Antimicrobial susceptibility patterns of E. coli

from clinical sources in northeast Ethiopia. Afr Health Sci 2011;

Suppl 1(Suppl 1):S40-S45.

Seelbach-Goebel B. Antibiotic Therapy for Premature Rupture

of Membranes and Preterm Labor and Effect on Fetal Outcome.

Geburtshilfe Frauenheilkd 2013; 73(12):1218-1227.

Navathe R, Schoen CN, Heidari P, Bachilova S, Ward A, Tepper

J, Visintainer P, Hoffman MK, Smith S, Berghella V, Roman A.

Azithromycin vs erythromycin for the management of preterm

premature rupture of membranes. Am J Obstet Gynecol 2019;


Pierson RC, Gordon SS, Haas DM. A retrospective comparison

of antibiotic regimens for preterm premature rupture of

membranes. Obstet Gynecol 2014; 124(3):515-519.

Gelber S, Brent E, Varrey A, Fridman B, Sapra K, Frayer W.

Equivalence of erythromycin and azithromycin for treatment of

PPROM. Am J Obstet Gynecol 2013; 208(1):S291.

Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das

AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant

morbidity after preterm premature rupture of the membranes: a

randomized controlled trial. JAMA 1997; 278(12):989-995

Desai SV, Tank P. Handbook on Preterm Prelabor Rupture of

Membranes in a Low Resource Setting. JAYPEE 2012; 35-36.

Nadisauskiene R, Bergström S, Kilda A. Ampicillin in the

treatment of preterm labor: a randomised, placebo-controlled

study. Gynecol Obstet Invest 1996; 41(2):89-92.

American Academy Of Pediatrics Committee On Fetus And

Newborn; American College Of Obstetricians And Gynecologists

Committee On Obstetric Practice. The Apgar Score. Pediatrics

; 136(4):819-822.

Salan YDC. Effect of Length of Premature Rupture of Membranes

Period toward Apgar Score of The Infant and Maternal Leukocyte

Serum in Ulin General Hospital Banjarmasin. Berkala Kedokteran

; 13:199-204.